Credit Suisse has initiated coverage with an Outperform rating and a Target Price of $124. Their FY21 underlying EBITDA forecast is $159m (vs $44m in FY20), which is the highest I have seen from the relatively large cohort of brokers covering the stock.
The UBS price target has been held at $30 (upgraded from $28.25 on 3 November).
- Forums
- ASX - By Stock
- APT
- Afterpay Valuation
Afterpay Valuation, page-3817
-
-
- There are more pages in this discussion • 2,995 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add APT (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
LGP
LITTLE GREEN PHARMA LTD
Paul Long, CEO
Paul Long
CEO
Previous Video
Next Video
SPONSORED BY The Market Online